Corvus Pharmaceuticals, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Corvus Pharmaceuticals, Inc. (CRVS) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $270.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-01
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $270.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $537.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $806.00K.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $279.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $270.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $537.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $806.00K 10-Q · filed 2018-05-03 |
| 2017-09-30 | $279.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $557.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $836.00K 10-Q · filed 2017-05-04 |
| 2016-09-30 | $226.00K 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |